logo

Ultragenyx Pharmaceutical Inc (RARE)



Trade RARE now with
  Date
  Headline
11/17/2017 8:21:50 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 2018 Estimate To -4.32 From -6.93
11/17/2017 8:21:31 AM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) 2017 Estimate To -7.49 From -4.55
11/17/2017 8:20:49 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) 2018 Rev. Estimate To 235.3 M From 111.0 M
11/7/2017 8:43:45 AM Ultragenyx Completes Acquisition Of Dimension Therapeutics
11/3/2017 2:12:52 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) FY18 Rev. Estimate To 111.0 M From 93.0 M
11/3/2017 2:11:16 PM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) FY18 Estimate To -6.93 From -5.96
11/3/2017 2:10:56 PM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) Q4 18 Estimate To -2.04 From -1.78
11/3/2017 2:10:33 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) Q3 18 Estimate To -0.72 From -1.78
11/3/2017 2:09:24 PM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) Q2 18 Estimate To -2.10 From -0.52
11/3/2017 2:08:26 PM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) Q1 18 Estimate To -2.08 From -1.87
11/3/2017 2:07:50 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) FY17 Estimate To -4.55 From -7.23
11/3/2017 2:04:46 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) Q4 17 Estimate To 0.67 From -1.98
11/2/2017 4:13:48 PM Ultragenyx Pharma Q3 Loss Per Share $1.87 Vs Loss $1.64 Last Year
11/1/2017 8:31:47 AM Ultragenyx, Kyowa Hakko Kirin Announce FDA Not Now Planning To Hold Advisory Committee Meeting For Burosumab BLA